CEO Kim Rodriguez Says Big Bet on Acessa Is Paying Off for Patients and Investors

Medtech Talk

English - September 20, 2019 19:00 - 32 minutes - 22.2 MB - ★★★★★ - 56 ratings
Investing Business Health & Fitness medtech medical device venture capital health care innovation cardiology start-ups orthopedics digital health fda Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Medtech VCs Klein, Nielsen Explain Why They Decided to Start Up Their Own Venture Firm, Vensana

Next Episode: Medtech CEO Duke Rohlen Grew Into His Name. Can AJAX Health Do the Same?

Kim Rodriguez expected to follow her mom’s career in medicine. But she got bit by the Medtech Bug early and enjoyed a string of sales success at companies of nearly every size including Cocentric, Spectranetics, and Guidant. But three years ago she got recruited to be CEO of a company that was rich in promising technologies as well as business challenges. In just three years, Rodriguez and her team at Acessa pulled out of the tail spin, secured FDA approval and a CPT code and now are building a promising women’s health company. In this episode, she’ll share how aspiring execs should ante up.